$LBRX 4 SEC Filings

Filed On	Filing
13 Oct 2026	Form 4: Kozauer Susan Gani, Chief Medical Officer Granted 200,000 Emplopyee Stock Option (Right to Buy)
13 Oct 2026	Form 4: Miller Joseph M, Chief Financial Officer Granted 200,000 Emplopyee Stock Option (Right to Buy)
03 Aug 2026	Form 4: Deep Track Biotechnology Master Fund, Ltd., 10% owner and 2 others Acquired 286,205 Pre-Funded Warrants (Right to Buy) (Open Market Purchase) ($10M)
05 Jun 2026	Form 4: Ruffolo Robert R, Director Granted 10,000 Stock Option (Right to Buy)
05 Jun 2026	Form 4: Nussbaum Ran, Director Granted 10,000 Stock Option (Right to Buy)
05 Jun 2026	Form 4: Luse Rebecca, Director Granted 10,000 Stock Option (Right to Buy)
05 Jun 2026	Form 4: Lenz Robert A., Director Granted 12,500 Stock Option (Right to Buy)
05 Jun 2026	Form 4: Hemrajani Rekha, Director Granted 10,000 Stock Option (Right to Buy)
05 Jun 2026	Form 4: Kane William P Jr, Director Granted 10,000 Stock Option (Right to Buy)
05 Jun 2026	Form 4: Garland J. Scott, Director Granted 10,000 Stock Option (Right to Buy)
10 Mar 2026	Form 4: Lenz Robert A., Director Granted 20,000 Stock Option (Right to Buy)
10 Feb 2026	Form 4: Deep Track Biotechnology Master Fund, Ltd., 10% owner and 3 others Acquired 472,369 Pre-Funded Warrants (Right to Buy) (Open Market Purchase) ($10M)
11 Dec 2025	Form 4: Pai Panandiker Kaya Kamlesh, Chief Commercial Officer Granted 195,000 Employee Stock Option (Right to Buy)
29 Sep 2025	Form 4: Panoff Marc L, Senior Vice President, Finance Disposed of 27,609 Employee Stock Option (Right to Buy) (Disposition to Issuer) · Granted 118,134 Employee Stock Option (Right to Buy)
16 Sep 2025	Form 4: Deep Track Biotechnology Master Fund, Ltd., 10% owner and 2 others Received 686,138 shares by conversion · Bought 2,666,666 shares ($40M)
16 Sep 2025	Form 4: Pontifax Management 4 G.p. (2015) Ltd., 10% owner Received 411,681 shares by conversion · Bought 1,000,000 shares ($15M)
16 Sep 2025	Form 4: Nussbaum Ran, Director Received 411,681 shares by conversion · Bought 1,000,000 shares ($15M)
16 Sep 2025	Form 4: Vida Ventures Gp III, L.l.c., 10% owner and 4 others Received 548,910 shares by conversion · Bought 333,333 shares ($5M)
12 Sep 2025	Form 4: Hemrajani Rekha, Director Granted 22,449 Stock Option (Right to Buy)
12 Sep 2025	Form 4: Luse Rebecca, Director Granted 22,449 Stock Option (Right to Buy)

Comments